Hyperpigmentation Disorder Treatment Market Size And Share

  • Report Code : TIPRE00029977
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 158
Buy Now

Hyperpigmentation Disorder Treatment Market Size, Share, and Forecast by 2030

Buy Now

Hyperpigmentation Disorder Treatment Market Report Hyperpigmentation Disorder Treatment Market Scope and Analysis Hyperpigmentation Disorder Treatment Market Size and Share

Hyperpigmentation Disorder Treatment Market: Strategic Insights

Hyperpigmentation Disorder Treatment Market

  • CAGR (2022 - 2030)
    7.4%
  • Market Size 2022
    US$ 6.68 Billion
  • Market Size 2030
    US$ 11.78 Billion

Market Dynamics

GROWTH DRIVERS
  • Rise in Prevalence of Melasma
  • Increasing Number of Hyperpigmentation Disorder Awareness Programs
FUTURE TRENDS
  • Use of Ablative Lasers
  • Novel Products Based on PATH-3 Technology
OPPORTUNITIES
  • Strategic Initiatives by Market Players

Key Players

  • AbbVie Inc
  • Bayer AG
  • Epipharm AG
  • Galderma Laboratories
  • Obagi Cosmeceuticals LLC
  • Lutronic Corporation
  • La Pristine
  • L oreal S A
  • Pierre Fabre Group
  • Vivier Pharma USA

Regional Overview

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • and South and Central America

Market Segmentation

Treatment Type
  • Cosmeceutical
  • Light or Laser Therapy
  • Microdermabrasion
  • Chemical Peels
  • Cryotherapy
Condition
  • Melasma
  • Solar Lentigines
  • Post-Inflammatory Hyperpigmentation
End User
  • Hospitals
  • Dermatology Centers